NDT Pharmaceuticals Inc.
NDTP - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$21.72M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $21.72 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0 |
| Beta | 0 |
| Outstanding Shares | 197,504,349 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -21.59 |
|---|---|
| PEG | -0.09 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About NDT Pharmaceuticals Inc.
0CEO: James Hovis
NDT Pharmaceuticals Inc., a biotechnology firm situated in Vienna, Virginia, is dedicated to formulating a range of treatments for serious neurological ailments, particularly those stemming from traumatic brain injuries.